nach oben

Current Psychiatry Reports

Erschienen in:

01.12.2014 | Substance Use and Related Disorders (F Levin and E Dakwar, Section Editors)

Neuroimaging and Biomarkers in Addiction Treatment

verfasst von: Kathleen A. Garrison, Marc N. Potenza

Erschienen in: Current Psychiatry Reports | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Neuroimaging studies have made a significant contribution to the efforts to identify measurable indices, or biomarkers, of addictions and their treatments. Biomarkers in addiction treatment are needed to provide targets for treatment, detect treatment subgroups, predict treatment response, and broadly improve outcomes. Neuroimaging is important to biomarkers research as it relates neural circuits to both molecular mechanisms and behavior. A focus of recent efforts in neuroimaging in addiction has been to elucidate the neural correlates associated with dimensions of functioning in substance-use and related disorders, such as cue-reactivity, impulsivity, and cognitive control, among others. These dimensions of functioning have been related to addiction treatment outcomes and relapse, and therefore, a better understanding of these dimensions and their neural correlates may help to identify brain-behavior biomarkers of treatment response. This paper reviews recent neuroimaging studies that report potential biomarkers in addiction treatment related to cue-reactivity, impulsivity, and cognitive control, as well as recent advances in neuroimaging that may facilitate efforts to determine reliable biomarkers. This important initial work has begun to identify possible mediators and moderators of treatment response, and multiple promising indices are being tested.

Volkow ND, Baler RD, Goldstein RZ. Addiction: pulling at the neural threads of social behaviors. Neuron. 2011;69(4):599–602. doi:10.1016/j.neuron.2011.01.027.CrossRefPubMedCentralPubMed

De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, et al. Considerations in the evaluation of surrogate endpoints in clinical trials. Summary of a National Institutes of Health workshop. Control Clin Trials. 2001;22(5):485–502.CrossRefPubMed

Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. 2013;11:126. doi:10.1186/1741-7015-11-126.

Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. AJ Psychiatry. 2010;167(7):748–51. doi:10.1176/appi.ajp.2010.09091379.CrossRef

Drummond DC. What does cue-reactivity have to offer clinical research? Addiction. 2000;95 Suppl 2:S129–44.CrossRefPubMed

Volkow ND, Baler RD. Brain imaging biomarkers to predict relapse in alcohol addiction. JAMA Psychiatry. 2013;70(7):661–3. doi:10.1001/jamapsychiatry.2013.1141.CrossRefPubMed

Lauritzen M. Reading vascular changes in brain imaging: is dendritic calcium the key? Nat Rev Neurosci. 2005;6(1):77–85. doi:10.1038/nrn1589.CrossRefPubMed

Laird AR, Fox PM, Price CJ, Glahn DC, Uecker AM, Lancaster JL, et al. ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum Brain Mapp. 2005;25(1):155–64. doi:10.1002/hbm.20136.CrossRefPubMed

Engelmann JM, Versace F, Robinson JD, Minnix JA, Lam CY, Cui Y, et al. Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies. Neuroimage. 2012;60(1):252–62. doi:10.1016/j.neuroimage.2011.12.024.CrossRefPubMedCentralPubMed

10.•

Chase HW, Eickhoff SB, Laird AR, Hogarth L. The neural basis of drug stimulus processing and craving: an activation likelihood estimation meta-analysis. Biol Psychiatry. 2011;70(8):785–93. doi:10.1016/j.biopsych.2011.05.025. Quantitative meta-analysis providing consensus across neuroimaging studies of cue-reactivity to drug and non-drug addiction-related cues and craving.CrossRefPubMed

11.

Kuhn S, Gallinat J. Common biology of craving across legal and illegal drugs—a quantitative meta-analysis of cue-reactivity brain response. Eur J Neurosci. 2011;33(7):1318–26. doi:10.1111/j.1460-9568.2010.07590.x.CrossRefPubMed

12.

Schacht JP, Anton RF, Myrick H. Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol. 2013;18(1):121–33. doi:10.1111/j.1369-1600.2012.00464.x.CrossRefPubMedCentralPubMed

13.

Tang DW, Fellows LK, Small DM, Dagher A. Food and drug cues activate similar brain regions: a meta-analysis of functional MRI studies. Physiol Behav. 2012;106(3):317–24. doi:10.1016/j.physbeh.2012.03.009.CrossRefPubMed

14.

Jasinska AJ, Stein EA, Kaiser J, Naumer MJ, Yalachkov Y. Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci Biobehav Rev. 2014;38:1–16. doi:10.1016/j.neubiorev.2013.10.013.CrossRefPubMedCentralPubMed

15.•

Seo D, Lacadie CM, Tuit K, Hong KI, Constable RT, Sinha R. Disrupted ventromedial prefrontal function, alcohol craving, and subsequent relapse risk. JAMA Psychiatry. 2013;70(7):727–39. doi:10.1001/jamapsychiatry.2013.762. fMRI study reporting a potential brain biomarker of alcohol cue-reactivity prospectively related to treatment relapse.CrossRefPubMedCentralPubMed

16.

Beck A, Wustenberg T, Genauck A, Wrase J, Schlagenhauf F, Smolka MN, et al. Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients. Arch Gen Psychiatry. 2012;69(8):842–52. doi:10.1001/archgenpsychiatry.2011.2026.CrossRefPubMed

17.

Janes AC, Pizzagalli DA, Richardt S, de Frederick B, Chuzi S, Pachas G, et al. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry. 2010;67(8):722–9. doi:10.1016/j.biopsych.2009.12.034.CrossRefPubMedCentralPubMed

18.

LaConte SM, King-Casas B, Cinciripini PM, Eagleman DM, Versace F, Chiu PH. Modulating rt-fMRI neurofeedback interfaces via craving and control in chronic smokers. Neuroimage. 2009;47(Supplement 1):S45–S.CrossRef

19.

LaConte SM. Decoding fMRI brain states in real-time. Neuroimage. 2011;56(2):440–54. doi:10.1016/j.neuroimage.2010.06.052.CrossRefPubMed

20.

Garrison KA, Scheinost D, Worhunsky PD, Elwafi HM, Thornhill TA, Thompson E, et al. Real-time fMRI links subjective experience with brain activity during focused attention. Neuroimage. 2013;81:110–8. doi:10.1016/j.neuroimage.2013.05.030.CrossRefPubMedCentralPubMed

21.

Stoeckel LE, Garrison KA, Ghosh S, Wighton P, Hanlon CA, Gilman JM, et al. Optimizing real time fMRI neurofeedback for therapeutic discovery and development. Neuroimage Clin. 2014;5:245–55. doi:10.1016/j.nicl.2014.07.002.CrossRefPubMedCentralPubMed

22.

Canterberry M, Hanlon CA, Hartwell KJ, Li X, Owens M, LeMatty T, et al. Sustained reduction of nicotine craving with real-time neurofeedback: exploring the role of severity of dependence. Nicotine Tob Res: Off J Soc Res Nicotine Tob. 2013;15(12):2120–4. doi:10.1093/ntr/ntt122.CrossRef

23.

Hanlon CA, Hartwell KJ, Canterberry M, Li X, Owens M, Lematty T, et al. Reduction of cue-induced craving through realtime neurofeedback in nicotine users: the role of region of interest selection and multiple visits. Psychiatry Res. 2013;213(1):79–81. doi:10.1016/j.pscychresns.2013.03.003.CrossRefPubMedCentralPubMed

24.

Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron. 2011;69(4):680–94. doi:10.1016/j.neuron.2011.01.020.CrossRefPubMed

25.

Robbins T, Curran H, de Wit H. Special issue on impulsivity and compulsivity. Psychopharmacology (Berl). 2012;219(2):251–2. doi:10.1007/s00213-011-2584-x.CrossRef

26.

Potenza MN, Sofuoglu M, Carroll KM, Rounsaville BJ. Neuroscience of behavioral and pharmacological treatments for addictions. Neuron. 2011;69(4):695–712. doi:10.1016/j.neuron.2011.02.009.CrossRefPubMedCentralPubMed

27.

Stevens L, Verdejo-Garcia A, Goudriaan AE, Roeyers H, Dom G, Vanderplasschen W. Impulsivity as a vulnerability factor for poor addiction treatment outcomes: a review of neurocognitive findings among individuals with substance use disorders. J Subst Abuse Treat. 2014;47(1):58–72. doi:10.1016/j.jsat.2014.01.008.CrossRefPubMed

28.

Loree AM, Lundahl LH, Ledgerwood DM. Impulsivity as a predictor of treatment outcome in substance use disorders: review and synthesis. Drug Alcohol Rev. 2014. doi:10.1111/dar.12132.PubMed

29.

Fineberg NA, Chamberlain SR, Goudriaan AE, Stein DJ, Vanderschuren LJ, Gillan CM, et al. New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. CNS Spectrums. 2014;19(1):69–89. doi:10.1017/S1092852913000801.CrossRefPubMedCentralPubMed

30.

Jupp B, Dalley JW. Behavioral endophenotypes of drug addiction: etiological insights from neuroimaging studies. Neuropharmacology. 2014;76:Pt B:487–97. doi:10.1016/j.neuropharm.2013.05.041.CrossRef

31.

Parvaz MA, Alia-Klein N, Woicik PA, Volkow ND, Goldstein RZ. Neuroimaging for drug addiction and related behaviors. Rev Neurosci. 2011;22(6):609–24. doi:10.1515/RNS.2011.055.CrossRefPubMedCentralPubMed

32.

Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F. Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A. 2011;108(37):15037–42. doi:10.1073/pnas.1010654108.CrossRefPubMedCentralPubMed

33.

Martinez D, Carpenter KM, Liu F, Slifstein M, Broft A, Friedman AC, et al. Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. AJ Psychiatry. 2011;168(6):634–41. doi:10.1176/appi.ajp.2010.10050748.CrossRef

34.

Wang GJ, Smith L, Volkow ND, Telang F, Logan J, Tomasi D, et al. Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry. 2012;17(9):918–25. doi:10.1038/mp.2011.86.CrossRefPubMedCentralPubMed

35.

Clark L, Stokes PR, Wu K, Michalczuk R, Benecke A, Watson BJ, et al. Striatal dopamine D(2)/D(3) receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage. 2012;63(1):40–6. doi:10.1016/j.neuroimage.2012.06.067.CrossRefPubMedCentralPubMed

36.

Jia Z, Worhunsky PD, Carroll KM, Rounsaville BJ, Stevens MC, Pearlson GD, et al. An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol Psychiatry. 2011;70(6):553–60. doi:10.1016/j.biopsych.2011.05.008.CrossRefPubMedCentralPubMed

37.

Yip SW, DeVito EE, Kober H, Worhunsky PD, Carroll KM, Potenza MN. Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: an exploratory study of relationships with abstinence during behavioral treatment. Drug Alcohol Depend. 2014;140:33–41. doi:10.1016/j.drugalcdep.2014.03.031.CrossRefPubMed

38.

Joos L, Goudriaan AE, Schmaal L, Fransen E, van den Brink W, Sabbe BG, et al. Effect of modafinil on impulsivity and relapse in alcohol dependent patients: a randomized, placebo-controlled trial. Eur Neuropsychopharmacol. 2013;23(8):948–55. doi:10.1016/j.euroneuro.2012.10.004.CrossRefPubMed

39.

Schmaal L, Joos L, Koeleman M, Veltman DJ, van den Brink W, Goudriaan AE. Effects of modafinil on neural correlates of response inhibition in alcohol-dependent patients. Biol Psychiatry. 2013;73(3):211–8. doi:10.1016/j.biopsych.2012.06.032.CrossRefPubMed

40.

Carter CS, van Veen V. Anterior cingulate cortex and conflict detection: an update of theory and data. Cogn Affect Behav Neurosci. 2007;7(4):367–79.CrossRefPubMed

41.

Sofuoglu M, DeVito EE, Waters AJ, Carroll KM. Cognitive enhancement as a treatment for drug addictions. Neuropharmacology. 2013;64:452–63. doi:10.1016/j.neuropharm.2012.06.021.CrossRefPubMedCentralPubMed

42.

Luijten M, Machielsen MW, Veltman DJ, Hester R, de Haan L, Franken IH. Systematic review of ERP and fMRI studies investigating inhibitory control and error processing in people with substance dependence and behavioural addictions. J Psychiatry Neurosci. 2014;39(3):149–69.CrossRefPubMedCentralPubMed

43.

Nestor LJ, Ghahremani DG, Monterosso J, London ED. Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects. Psychiatry Res. 2011;194(3):287–95. doi:10.1016/j.pscychresns.2011.04.010.CrossRefPubMedCentralPubMed

44.

Sorg SF, Taylor MJ, Alhassoon OM, Gongvatana A, Theilmann RJ, Frank LR, et al. Frontal white matter integrity predictors of adult alcohol treatment outcome. Biol Psychiatry. 2012;71(3):262–8. doi:10.1016/j.biopsych.2011.09.022.CrossRefPubMedCentralPubMed

45.

Worhunsky PD, Stevens MC, Carroll KM, Rounsaville BJ, Calhoun VD, Pearlson GD, et al. Functional brain networks associated with cognitive control, cocaine dependence, and treatment outcome. Psychol Addict Behav. 2013;27(2):477–88. doi:10.1037/a0029092.CrossRefPubMedCentralPubMed

46.

Marhe R, Luijten M, Franken IH. The clinical relevance of neurocognitive measures in addiction. Front Psychiatry. 2014;4:185. doi:10.3389/fpsyt.2013.00185.CrossRefPubMedCentralPubMed

47.•

Luo X, Zhang S, Hu S, Bednarski SR, Erdman E, Farr OM, et al. Error processing and gender-shared and -specific neural predictors of relapse in cocaine dependence. Brain. 2013;136(Pt 4):1231–44. doi:10.1093/brain/awt040. fMRI study reporting reduced activity in the dorsal anterior cingulate cortex during error processing that is related prospectively to cocaine relapse and earlier time to relapse.CrossRefPubMedCentralPubMed

48.

Marhe R, van de Wetering BJ, Franken IH. Error-related brain activity predicts cocaine use after treatment at 3-month follow-up. Biol Psychiatry. 2013;73(8):782–8. doi:10.1016/j.biopsych.2012.12.016.CrossRefPubMed

49.

MacLeod CM. Half a century of research on the Stroop effect: an integrative review. Psychol Bull. 1991;109(2):163–203.CrossRefPubMed

50.

Potenza MN, Balodis IM, Franco CA, Bullock S, Xu J, Chung T, et al. Neurobiological considerations in understanding behavioral treatments for pathological gambling. Psychol Addict Behav. 2013;27(2):380–92. doi:10.1037/a0032389.CrossRefPubMedCentralPubMed

51.

DeVito EE, Worhunsky PD, Carroll KM, Rounsaville BJ, Kober H, Potenza MN. A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend. 2012;122(3):228–35. doi:10.1016/j.drugalcdep.2011.10.002.CrossRefPubMedCentralPubMed

52.

Brewer JA, Worhunsky PD, Carroll KM, Rounsaville BJ, Potenza MN. Pretreatment brain activation during Stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry. 2008;64(11):998–1004. doi:10.1016/j.biopsych.2008.05.024.CrossRefPubMedCentralPubMed

53.

Krishnan-Sarin S, Balodis IM, Kober H, Worhunsky PD, Liss T, Xu J, et al. An exploratory pilot study of the relationship between neural correlates of cognitive control and reduction in cigarette use among treatment-seeking adolescent smokers. Psychol Addict Behav. 2013;27(2):526–32. doi:10.1037/a0032479.CrossRefPubMedCentralPubMed

54.

Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, et al. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry. 2010;67(8):715–21. doi:10.1016/j.biopsych.2010.01.016.CrossRefPubMed

55.

Ghahremani DG, Tabibnia G, Monterosso J, Hellemann G, Poldrack RA, London ED. Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology. 2011;36(5):950–9. doi:10.1038/npp.2010.233.CrossRefPubMedCentralPubMed

56.

Goldstein RZ, Woicik PA, Maloney T, Tomasi D, Alia-Klein N, Shan J, et al. Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task. Proc Natl Acad Sci U S A. 2010;107(38):16667–72. doi:10.1073/pnas.1011455107.CrossRefPubMedCentralPubMed

57.

Li CS, Morgan PT, Matuskey D, Abdelghany O, Luo X, Chang JL, et al. Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients. Proc Natl Acad Sci U S A. 2010;107(32):14455–9. doi:10.1073/pnas.1002467107.CrossRefPubMedCentralPubMed

58.

Sofuoglu M, Waters AJ, Poling J, Carroll KM. Galantamine improves sustained attention in chronic cocaine users. Exp Clin Psychopharmacol. 2011;19(1):11–9. doi:10.1037/a0022213.CrossRefPubMedCentralPubMed

59.

Sofuoglu M, Carroll KM. Effects of galantamine on cocaine use in chronic cocaine users. Am J Addict. 2011;20(3):302–3. doi:10.1111/j.1521-0391.2011.00130.x.CrossRefPubMedCentralPubMed

60.

Janes AC, Nickerson LD, Frederick Bde B, Kaufman MJ. Prefrontal and limbic resting state brain network functional connectivity differs between nicotine-dependent smokers and non-smoking controls. Drug Alcohol Depend. 2012;125(3):252–9. doi:10.1016/j.drugalcdep.2012.02.020.CrossRefPubMedCentralPubMed

61.

Gordon EM, Devaney JM, Bean S, Vaidya CJ. Resting-state striato-frontal functional connectivity is sensitive to DAT1 genotype and predicts executive function. Cereb Cortex. 2013. doi:10.1093/cercor/bht229.

62.

Muller VI, Langner R, Cieslik EC, Rottschy C, Eickhoff SB. Interindividual differences in cognitive flexibility: influence of gray matter volume, functional connectivity and trait impulsivity. Brain Struct Funct. 2014. doi:10.1007/s00429-014-0797-6.

63.

Sutherland MT, McHugh MJ, Pariyadath V, Stein EA. Resting state functional connectivity in addiction: lessons learned and a road ahead. Neuroimage. 2012;62(4):2281–95. doi:10.1016/j.neuroimage.2012.01.117.CrossRefPubMedCentralPubMed

64.

Camchong J, Stenger A, Fein G. Resting-state synchrony during early alcohol abstinence can predict subsequent relapse. Cereb Cortex. 2013;23(9):2086–99. doi:10.1093/cercor/bhs190.CrossRefPubMedCentralPubMed

65.

McHugh MJ, Demers CH, Salmeron BJ, Devous Sr MD, Stein EA, Adinoff B. Cortico-amygdala coupling as a marker of early relapse risk in cocaine-addicted individuals. Front Psychiatry. 2014;5:16. doi:10.3389/fpsyt.2014.00016.CrossRefPubMedCentralPubMed

66.•

Konova AB, Moeller SJ, Tomasi D, Volkow ND, Goldstein RZ. Effects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction. JAMA Psychiatry. 2013;70(8):857–68. doi:10.1001/jamapsychiatry.2013.1129. Resting state fMRI study of a pharmacological intervention for cocaine addiction demonstrating that changes in functional connectivity may be a potential mechanism of treatment effects.CrossRefPubMedCentralPubMed

67.

Schmaal L, Goudriaan AE, Joos L, Kruse AM, Dom G, van den Brink W, et al. Modafinil modulates resting-state functional network connectivity and cognitive control in alcohol-dependent patients. Biol Psychiatry. 2013;73(8):789–95. doi:10.1016/j.biopsych.2012.12.025.CrossRefPubMed

68.

Cole DM, Oei NY, Soeter RP, Both S, van Gerven JM, Rombouts SA, et al. Dopamine-dependent architecture of cortico-subcortical network connectivity. Cereb Cortex. 2013;23(7):1509–16. doi:10.1093/cercor/bhs136.CrossRefPubMed

69.•

Lerman C, Gu H, Loughead J, Ruparel K, Yang Y, Stein EA. Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. JAMA Psychiatry. 2014;71(5):523–30. doi:10.1001/jamapsychiatry.2013.4091. Resting state fMRI connectivity study linking an index of large-scale network dynamics to craving and withdrawal during short-term abstinence, with implications for treatment.CrossRefPubMedCentralPubMed

70.

Laird AR, Eickhoff SB, Rottschy C, Bzdok D, Ray KL, Fox PT. Networks of task co-activations. Neuroimage. 2013;80:505–14. doi:10.1016/j.neuroimage.2013.04.073.CrossRefPubMedCentralPubMed

71.

Biswal BB, Mennes M, Zuo XN, Gohel S, Kelly C, Smith SM, et al. Toward discovery science of human brain function. Proc Natl Acad Sci U S A. 2010;107(10):4734–9. doi:10.1073/pnas.0911855107.CrossRefPubMedCentralPubMed

72.

Craddock RC, Jbabdi S, Yan CG, Vogelstein JT, Castellanos FX, Di Martino A, et al. Imaging human connectomes at the macroscale. Nat Methods. 2013;10(6):524–39. doi:10.1038/nmeth.2482.CrossRefPubMedCentralPubMed

73.

Smith SM, Vidaurre D, Beckmann CF, Glasser MF, Jenkinson M, Miller KL, et al. Functional connectomics from resting-state fMRI. Trends Cogn Sci. 2013;17(12):666–82. doi:10.1016/j.tics.2013.09.016.CrossRefPubMedCentralPubMed

74.

Kober H, Mende-Siedlecki P, Kross EF, Weber J, Mischel W, Hart CL, et al. Prefrontal-striatal pathway underlies cognitive regulation of craving. Proc Natl Acad Sci U S A. 2010;107(33):14811–6. doi:10.1073/pnas.1007779107.CrossRefPubMedCentralPubMed

75.

Xu J, Kober H, Wang X, DeVito EE, Carroll KM, Potenza MN. Hippocampal volume mediates the relationship between measures of pre-treatment cocaine use and within-treatment cocaine abstinence. Drug Alcohol Depend. In press.

76.•

Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET. Abnormal brain structure implicated in stimulant drug addiction. Science. 2012;335(6068):601–4. doi:10.1126/science.1214463. Diffusion tensor imaging study demonstrating common structural abnormalities in brain regions implicated in self-control in drug-addicted individuals and their non-addicted siblings, suggesting a potential neurocognitive endophenotype for drug addiction.CrossRefPubMed

77.

Wagner M, Schulze-Rauschenbach S, Petrovsky N, Brinkmeyer J, von der Goltz C, Grunder G, et al. Neurocognitive impairments in non-deprived smokers—results from a population-based multi-center study on smoking-related behavior. Addict Biol. 2013;18(4):752–61. doi:10.1111/j.1369-1600.2011.00429.x.CrossRefPubMed

78.

Morgenstern J, Naqvi NH, Debellis R, Breiter HC. The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction. Psychol Addict Behav. 2013;27(2):336–50. doi:10.1037/a0032435.CrossRefPubMedCentralPubMed

79.

Robinson JL, Laird AR, Glahn DC, Lovallo WR, Fox PT. Metaanalytic connectivity modeling: delineating the functional connectivity of the human amygdala. Hum Brain Mapp. 2010;31(2):173–84. doi:10.1002/hbm.20854.PubMedCentralPubMed

80.

Yarkoni T, Poldrack RA, Nichols TE, Van Essen DC, Wager TD. Large-scale automated synthesis of human functional neuroimaging data. Nat Methods. 2011;8(8):665–70. doi:10.1038/nmeth.1635.CrossRefPubMedCentralPubMed

81.

Wager TD, Lindquist M, Kaplan L. Meta-analysis of functional neuroimaging data: current and future directions. Soc Cogn Affect Neurosci. 2007;2(2):150–8.CrossRefPubMedCentralPubMed

Titel: Neuroimaging and Biomarkers in Addiction Treatment
verfasst von: Kathleen A. Garrison
Marc N. Potenza
Publikationsdatum: 01.12.2014
Verlag: Springer US
Erschienen in: Current Psychiatry Reports / Ausgabe 12/2014
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-014-0513-5

Neu im Fachgebiet Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Neuroimaging and Biomarkers in Addiction Treatment

Abstract

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2014

The Use of Electronic Games in Therapy: a Review with Clinical Implications

Hormone Replacement Therapy in the Treatment of Perimenopausal Depression

Internet Interventions for Mental Health and Addictions: Current Findings and Future Directions

New Measures of Mental State and Behavior Based on Data Collected From Sensors, Smartphones, and the Internet

Professional Social Networking

Proceed with Caution: Off-label Ketamine Treatment for Major Depressive Disorder

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie